Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/97044
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGallego, Xavier-
dc.contributor.authorMurtra, Patricia-
dc.contributor.authorZamalloa, Teresa-
dc.contributor.authorCanals i Coll, Josep M.-
dc.contributor.authorPineda, Joseba-
dc.contributor.authorAmador Arjona, Alejandro-
dc.contributor.authorMaldonado, Rafael, 1961--
dc.contributor.authorDierssen, Mara-
dc.date.accessioned2016-04-06T12:28:18Z-
dc.date.available2016-04-06T12:28:18Z-
dc.date.issued2010-
dc.identifier.issn1662-5153-
dc.identifier.urihttp://hdl.handle.net/2445/97044-
dc.description.abstractPanic disorder is a highly prevalent neuropsychiatric disorder that shows co-occurrence with substance abuse. Here, we demonstrate that TrkC, the high-affinity receptor for neurotrophin-3, is a key molecule involved in panic disorder and opiate dependence, using a transgenic mouse model (TgNTRK3). Constitutive TrkC overexpression in TgNTRK3 mice dramatically alters spontaneous firing rates of locus coeruleus (LC) neurons and the response of the noradrenergic system to chronic opiate exposure, possibly related to the altered regulation of neurotrophic peptides observed. Notably, TgNTRK3 LC neurons showed an increased firing rate in saline-treated conditions and profound abnormalities in their response to met5-enkephalin. Behaviorally, chronic morphine administration induced a significantly increased withdrawal syndrome in TgNTRK3 mice. In conclusion, we show here that the NT-3/TrkC system is an important regulator of neuronal firing in LC and could contribute to the adaptations of the noradrenergic system in response to chronic opiate exposure. Moreover, our results indicate that TrkC is involved in the molecular and cellular changes in noradrenergic neurons underlying both panic attacks and opiate dependence and support a functional endogenous opioid deficit in panic disorder patients.-
dc.format.extent14 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherFrontiers Media-
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.3389/neuro.08.060.2009-
dc.relation.ispartofFrontiers in Behavioral Neuroscience, 2010, vol. 3-
dc.relation.urihttp://dx.doi.org/10.3389/neuro.08.060.2009-
dc.rightscc-by (c) Gallego, X. et al., 2010-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Biomedicina)-
dc.subject.classificationTrastorns de pànic-
dc.subject.classificationAbús de substàncies-
dc.subject.classificationRates (Animals de laboratori)-
dc.subject.classificationAnimals transgènics-
dc.subject.classificationOpiacis-
dc.subject.otherPanic disorders-
dc.subject.otherSubstance abuse-
dc.subject.otherRats as laboratory animals-
dc.subject.otherTransgenic animals-
dc.subject.otherOpioids-
dc.titleIncreased opioid dependence in a mouse model of panic disorder-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec582597-
dc.date.updated2016-04-06T12:28:23Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid20204153-
Appears in Collections:Articles publicats en revistes (Biomedicina)

Files in This Item:
File Description SizeFormat 
582597.pdf3.48 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons